As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Director of Communications, CFIDS Association of America, Charlotte, North Carolina
Disclosure: Marcia Harmon has disclosed no relevant financial relationships.
Director, Fatigue Consultation Clinic, Salt Lake Regional Hospital, Salt Lake City, Utah
Disclosure: Lucinda Bateman, MD, has disclosed that she serves as principal investigator for a phase 3 drug trial for Hemispherx Biopharma.
Assistant Consulting Professor, Duke University Medical Center, Durham, North Carolina; Medical Director, Hunter-Hopkins Center, Charlotte, North Carolina
Disclosure: Charles W. Lapp, MD, has disclosed that he has received grants for clinical research from Pfizer, Eli Lilly, Schwarz, and Boehringer Ingelheim. Dr. Lapp has also disclosed that he has served as a speaker for Pfizer and Eli Lilly.
President and CEO, The CFIDS Association of America, Charlotte, North Carolina
Disclosure: K. Kimberly McCleary has disclosed no relevant financial relationships.
Nurse Planner, Medscape; Adjunct Assistant Professor, School of Health Sciences, George Washington University, Washington, DC; Curriculum Coordinator, Nurse Practitioner Alternatives, Inc., Ellicott City; Nurse Practitioner, Baltimore City School-Based Health Centers, Baltimore, Maryland
Disclosure: Laurie E. Scudder, MS, NP-C, has disclosed that she has no relevant financial relationships.
Editorial Director, Medscape Nurses
Disclosure: Susan Yox, RN, EdD, has disclosed no relevant financial relationships.
processing....
The prevalence of CFS and the level of debilitation and disability that can accompany the illness -- and the cost to our healthcare system and economy -- result in a burden of illness of considerable dimensions. Although CFS is complex, and there is no cure, clinicians and the broader healthcare community can help reduce the burden of this illness through early diagnosis and intervention.
Diagnosing CFS can be time-consuming because symptoms are common to other diseases, and there is no diagnostic test. However, the process of sorting through symptoms and assessing abnormalities is no different from clinical assessment of other conditions. Like many other diseases, CFS symptoms form a specific pattern that, when combined with exclusionary laboratory tests, are diagnostic.
Effectively managing CFS is more challenging than diagnosing the illness, but there are many treatment options that can help. Working together, clinicians and patients can develop individualized treatment plans to reduce symptoms, improve function, and enhance quality of life. Establishing a good patient/provider partnership can also help break the cycle of frustration that often occurs between clinicians and patients who have difficult-to-manage chronic illnesses.
Thank you for participating in the CME/CE activity. Please take a few moments to read the following cases and complete the questions that follow to help us assess the effectiveness of this medical education activity.
Medscape Nurses © 2008
Medscape.